Literature DB >> 9688066

Chemical pathways of peptide degradation: IX. Metal-catalyzed oxidation of histidine in model peptides.

M Khossravi1, R T Borchardt.   

Abstract

PURPOSE: To elucidate the nature of the reactive oxygen species (i.e., superoxide anion radical, hydroxyl radical, and hydrogen peroxide) involved in the metal-catalyzed oxidation of histidine (His) in two model peptides.
METHODS: The degradation of AcAla-His-ValNH2 (Ala-peptide) and AcCysNH2-S-S-AcCys-His-VaNH2 (Cys-peptide) was investigated at pH 5.3 and 7.4 in an ascorbate/cupric chloride/oxygen (ascorbate/ Cu(II)/O2) system, both in the absence and presence of selective scavengers (i.e., catalase, superoxide dismutase, mannitol, sodium formate, isopropanol, and thiourea) of the reactive oxygen species. All reactions were monitored by HPLC. The major degradation products were characterized by electrospray mass spectrometry.
RESULTS: The Cys-peptide was more stable than the Ala-peptide at pH 5.3 and 7.4. Both peptides displayed greater stability at pH 5.3 than at 7.4. At pH 5.3, 35 +/- 0.7% of the Cys-peptide and 18 +/- 1% of the Ala-peptide remained after 7 hours, whereas at pH 7.4, 16 +/- 3% of the Cys-peptide and 4 +/- 1% of the Ala-peptide remained. Catalase, thiourea, bicinchoninic acid, and ethylenediaminetetraacetate were effective at stabilizing both peptides toward oxidation, while superoxide dismutase, mannitol, isopropanol, and sodium formate were ineffective. The main degradation products of the Ala- and Cys-peptides at pH 7.4 appeared to be AcAla-2-oxo-His-ValNH2 and AcCysNH2-S-S-AcCys-2-oxo-His-ValNH2, respectively.
CONCLUSIONS: Hydrogen peroxide, Cu(I), and superoxide anion radical were deduced to be intermediates involved in the oxidation of the Ala- and Cys-peptides. Hydrogen peroxide degradation to secondary reactive oxygen species may have led to the oxidation of the peptides. The degradation of hydrogen peroxide by a Fenton-type reaction was speculated to form a complexed form of hydroxyl radical that reacts with the peptide before diffusion into the bulk solution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688066     DOI: 10.1023/a:1011946631197

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization.

Authors:  S Li; C Schöneich; R T Borchardt
Journal:  Biotechnol Bioeng       Date:  1995-12-05       Impact factor: 4.530

Review 2.  Superoxide dismutases. An adaptation to a paramagnetic gas.

Authors:  I Fridovich
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

3.  Evaluation of the interaction of peptides with Cu(II), Ni(II), and Zn(II) by high-performance immobilized metal ion affinity chromatography.

Authors:  T T Yip; Y Nakagawa; J Porath
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

4.  Metal-catalyzed oxidation of histidine in human growth hormone. Mechanism, isotope effects, and inhibition by a mild denaturing alcohol.

Authors:  F Zhao; E Ghezzo-Schöneich; G I Aced; J Hong; T Milby; C Schöneich
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

5.  The kinetics of relaxin oxidation by hydrogen peroxide.

Authors:  T H Nguyen; J Burnier; W Meng
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

6.  Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118.

Authors:  K Uchida; S Kawakishi
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

7.  Coordination modes of histidine. 4. Coordination structures in the copper(II)-L-histidine (1:2) system.

Authors:  L Casella; M Gullotti
Journal:  J Inorg Biochem       Date:  1983-02       Impact factor: 4.155

8.  Effects of polyaminocarboxylate metal chelators on iron-thiolate induced oxidation of methionine- and histidine-containing peptides.

Authors:  F Zhao; J Yang; C Schöneich
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

9.  Effect of radical scavengers on the inactivation of papain by ascorbic acid in the presence of cupric ions.

Authors:  H Kanazawa; S Fujimoto; A Ohara
Journal:  Biol Pharm Bull       Date:  1994-04       Impact factor: 2.233

10.  Studies of the limited degradation of mucus glycoproteins. The effect of dilute hydrogen peroxide.

Authors:  J M Creeth; B Cooper; A S Donald; J R Clamp
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

View more
  6 in total

1.  Chemical pathways of peptide degradation. X: effect of metal-catalyzed oxidation on the solution structure of a histidine-containing peptide fragment of human relaxin.

Authors:  M Khossravi; R T Borchardt
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

2.  Metal ion interactions with mAbs: Part 1.

Authors:  Zephania Kwong Glover; Louisette Basa; Benjamin Moore; Jennifer S Laurence; Alavattam Sreedhara
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Labeling live cells by copper-catalyzed alkyne--azide click chemistry.

Authors:  Vu Hong; Nicole F Steinmetz; Marianne Manchester; M G Finn
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

4.  Chemoproteomic Method for Profiling Inhibitor-Bound Kinase Complexes.

Authors:  Linglan Fang; Sujata Chakraborty; Emily M Dieter; Zachary E Potter; Chloe K Lombard; Dustin J Maly
Journal:  J Am Chem Soc       Date:  2019-07-05       Impact factor: 15.419

5.  Metal-catalyzed oxidation of protein methionine residues in human parathyroid hormone (1-34): formation of homocysteine and a novel methionine-dependent hydrolysis reaction.

Authors:  Olivier Mozziconacci; Junyan A Ji; Y John Wang; Christian Schöneich
Journal:  Mol Pharm       Date:  2013-01-23       Impact factor: 4.939

6.  In vitro reactive oxygen species production by histatins and copper(I,II).

Authors:  Eric A Houghton; Kenneth M Nicholas
Journal:  J Biol Inorg Chem       Date:  2008-10-31       Impact factor: 3.358

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.